SmallCapPodcast.com
AGORACOM Small Cap TV AGORACOM Small-Cap Gold and Resources TV Chinese Small Cap Stock TV
LISTEN NOW LISTEN NOW LISTEN NOW
Apr 27, 2020 | by admin | Permalink

Agoracom interviews CEOs of small cap companies.

In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Else Nutrition (TSX-V:BABY) Co-founder and CEO, Hamutal Yitzhak.

When the subsidiary of a Billion Dollar, Nutrition Focused company buys 11.5% of your stock, agrees to a voluntary 12-month lock up and holds anti-dilution rights to maintain it’s ownership percentage by buying a proportionate number of shares in any future financing, it is safe to assume you have a strategic investor who believes in the future of your company.

When that same strategic investor wants to then help your company expand into large international markets, it is safe to assume your plant based food capabilities are amongst the most respected in the world.

This is just a glimpse into the strength of Else Nutrition (BABY:TSXV) (BABYF:OTCQB), an Israeli based, award winning plant based food nutrition company that is giving small cap investors an opportunity to participate in the global paradigm shift towards plant-based, clean label foods.

BUT THERE IS MORE

* Else has a $10,000,000 war chest for a US product launch in Q2 and to start signing international agreements in Q3.
* These global plans are supported by patents in 22 countries, with another 44 countries pending.
* Else developed the world’s first 100% plant based, non-dairy, non-soy baby formula

Given all of these achievements, it should come as no surprise that Else Nutrition is made up of Executives & Advisors from globally renowned companies and institutions.

If you believe in the future of plant-based, clean label foods or want to discover its possibilities, then watch our first ever interview with Hamutal Yitzhak, the CEO and Co-Founder of Else Nutrition who will tell you about both the Company’s origins and future path!

Download This Episode

View Company Website

Visit Investor Relations Hub